Physician profile
Anna Baur
NPI 1609262153
$3,864.07
in general payments reported to CMS, 2019-2025
37 companies · $626 in 2025
The $626 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $485 · 2021: $549 · 2022: $577 · 2023: $696 · 2024: $600 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $624.75 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Amgen INC. | $299.41 | 2019-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $291.50 | 2019-2025 | |
| Astellas Pharma US INC | $222.75 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $212.25 | 2021-2025 | |
| Exeltis, USA INC. | $210.30 | 2020-2024 | Slynd |
| Organon LLC | $203.99 | 2021-2025 | Nexplanon, Jada System |
| Lupin INC. | $191.69 | 2019-2021 | |
| Hologic Sales and Service, LLC | $171.82 | 2021-2025 | Acessa Provu System |
| Coopersurgical, INC. | $157.81 | 2022-2025 | Paragard T 380a, Endosee, Paragard T 380a |
| Pfizer INC. | $137.08 | 2019-2023 | |
| Radius Health, INC. | $123.69 | 2023-2025 | Tymlos |
| Myovant Sciences INC. | $119.10 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $103.95 | 2023-2025 | Gemtesa, Myfembree |
| Optumhealth Care Solutions, LLC | $78.83 | 2023-2025 | Vivify Health Care Team Portal, Eitan Medical, Vivify Health Care Team Portal 001 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $65.86 | 2023-2024 | Accrufer |
| Agile Therapeutics, INC. | $61.26 | 2022 | |
| Novo Nordisk INC | $59.51 | 2023-2024 | |
| Exact Sciences Corporation | $59.27 | 2024-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $55.02 | 2020-2022 | |
| Davol INC. | $47.21 | 2023 | Arista Ah Flexitip |
| Mimedx Group, INC. | $46.82 | 2024 | |
| Merck Sharp & Dohme LLC | $34.97 | 2019-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Evofem Biosciences, INC. | $32.80 | 2021-2023 | Phexxi |
| Millicent US INC | $30.21 | 2025 | Intrarosa, Femring, Femlyv |
| Lundbeck LLC | $29.88 | 2022 | |
| Therapeuticsmd, INC. | $29.56 | 2020 | |
| Amag Pharmaceuticals, INC. | $25.12 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.30 | 2025 | |
| Daiichi Sankyo INC. | $16.84 | 2020 | |
| Medtronic, INC. | $16.82 | 2023 | Kyphon Express II Kyphopak Tray |
| Biogen, INC. | $16.74 | 2025 | Zurzuvae |
| Renovia INC | $15.66 | 2021 | |
| Tactile Systems Technology INC | $15.27 | 2020 | |
| Duchesnay USA Incorporated | $14.85 | 2020 | |
| Allergan, INC. | $12.40 | 2020 | |
| Minerva Surgical, INC | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Baur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.